How'd you fix Pear Therapeutics's revenue issues in 2026?
Direct Answer Pear Therapeutics is not a 2026 revenue story—it's a post-bankruptcy IP acquisition play. Click Therapeutics (actual buyer) and a 2026 successor need to: (1) Pivot reSET, reSET-O, and Somryst from prescription-reimbursement (d…
Read full answer ↗